| On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week. Special Announcements Climate and Health Scholars Program announced
This new program seeks to bring climate and health focused scientists from outside the U.S. federal government to work with NIH staff to build climate and health capacity. 2022‐2023 NIH Climate and Health Scholars Program [PDF]
Applications due: September 15 Extended Grants.gov Downtime Impacts September 22-30 Due Dates
This notice informs the community of NIH and AHRQ application due date adjustments to accommodate scheduled federal system downtime. Adjustments to NIH and AHRQ Grant Application Due Dates Between September 22 and September 30, 2022 (NOT-OD-22-190) Just announced LMIC-related funding opportunities Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional) (RFA-CA-22-019)
Application Receipt Date(s): November 8, 2022 Upcoming Deadlines for Fogarty Funding Opportunities HIV Research Training
Application deadline: August 22, 2022 Japanese Research Fellowships
Application deadline: September 30, 2022 Funding Opportunities NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply: AD/ADRD, Adverse Childhood Experiences, and Social Determinants of Health Ancillary Studies of Existing Longitudinal Cohorts (R01 - Clinical Trial Not Allowed) (PAR-22-221)
Application Receipt Date(s): October 5, 2022 Molecular Phenotypes of Null Alleles in Cells (MorPhiC) Phase I: Data Analysis and Validation Centers (U01 Clinical trials not allowed) (RFA-HG-22-019)
Application Receipt Date(s): November 1, 2022. Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed) (PAR-22-215)
Application Receipt Date(s): Multiple dates, see announcement. HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain (R01 Clinical Trial Not Allowed) (RFA-NS-22-070)
Application Receipt Date(s): Multiple dates, see announcement. Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed) (PAR-22-223)
Application Receipt Date(s): Multiple dates, see announcement. NIH funding opportunities for which foreign components may apply: Connecting Machine Readable Digital Human AD/ADRD Neuropathological Library Platforms for Advanced Analytics (U24 Clinical Trial Not Allowed) (RFA-NS-22-062)
Application Receipt Date(s): November 04, 2022 REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed) (RFA-AT-23-004)
Application Receipt Date(s): November 10, 2022 Allergy and Asthma Statistical and Clinical Coordinating Center (AA-SCCC) (U01 Clinical Trial Not Allowed) (RFA-AI-22-054)
Application Receipt Date(s): November 30, 2022 Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed) (RFA-AI-22-057)
Application Receipt Date(s): November 30, 2022 National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed) (RFA-AI-22-058)
Application Receipt Date(s): November 30, 2022 NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed (PAR-22-205)
Application Receipt Date(s): Multiple dates, see announcement. NIDA’s Racial Equity Initiative (REI) announcments: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed) (RFA-DA-23-025)
Application Receipt Date(s): November 15, 2022 Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) (RFA-DA-23-013)
Application Receipt Date(s): Multiple dates, see announcement. Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional) (RFA-DA-23-023)
Application Receipt Date(s): Multiple dates, see announcement. Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional) (RFA-DA-23-024)
Application Receipt Date(s): Multiple dates, see announcement. Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional) (RFA-DA-23-026)
Application Receipt Date(s): Multiple dates, see announcement. Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) (RFA-DA-23-028)
Application Receipt Date(s): Multiple dates, see announcement. Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) (RFA-DA-23-029)
Application Receipt Date(s): Multiple dates, see announcement. Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional) (RFA-DA-23-031)
Application Receipt Date(s): Multiple dates, see announcement. Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional) (RFA-DA-23-032)
Application Receipt Date(s): Multiple dates, see announcement. Other Funding News General NIH notices that may be of interest to global health researchers: New NIH "FORMS-H" Grant Application Forms and Instructions Coming for Due Dates on or after January 25, 2023 Review of the Accuracy of Grants Information for Fiscal Year 2022 Pre-Application Webinars RFA-DK-22-001 Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed) RFA-DK-22-019, Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed) Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC³H-IN) Funding Opportunity Announcements Notices of Information: High-Priority Principles of Rigorous Research for NINDS Materials to Enhance Training in Experimental Rigor (METER) Funding Opportunity Technical Assistance Webinar for the Clinical and Translational Science Award Program Notice of changes to funding opportunities that may be of interest to global health researchers: Corrections RFA-DA-23-053, "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)" (NOT-DA-22-066) Key Dates for RFA-NS-22-040 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)" (NOT-NS-22-112) Notice of Change to RFA-NS-21-010 "HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)" (NOT-NS-23-016) Notices of intent to publish funding opportunities that may be of interest to global health researchers: Diversity Centers for Genome Research (U54 Clinical Trials Optional) (NOT-HG-22-030) Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional) (NOT-HG-22-031) NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers: Administrative Supplements for NIA-VA Mentored Physician and Clinical Psychologist Scientist Award in Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (NOT-AG-22-020)
Expiration date: December 31, 2023 Research on the Health of Bisexual and Bisexual+ People (NOT-OD-22-166)
Expiration date: May 08, 2025 Non-NIH funding opportunities that may be of interest to global health researchers: Covenant Applied Informatics and Communication Africa Centre of Excellence (CApIC-ACE) at Covenant University in Ota, Nigeria, invites applicants from Nigeria and West & Central Africa into its masters and Ph.D. programs in Bioinformatics, Computer Science, Biochemistry, Microbiology, and Information & Communication Engineering (ICE). Sponsorship and intense three-month English language training (for French speaking applicants) available.
Application deadline: August 19, 2022 The OWSD - Elsevier Foundation Awards for Early Career Women Scientists in the Developing World encourage women working and living in developing countries who are in the early stages of their scientific careers. Awardees must have made a demonstrable impact on the research environment, both at a regional and international level, and must have received their Ph.D. in STEM in the last ten years.
Application deadline: September 15, 2022 The American Association for Cancer Research has two grants with deadlines in September: Beginning Investigator Grant For Catalytic Research (Big Cat) is an initiative by the African Organization for Research and Training in Cancer (AORTIC) to build capacity for cancer research in Africa.
Letter of intent deadline: September 7, 2022 Monarca (Maximizing Opportunity For New Advancements In Research In Cancer) Grant For Latin America supports early-career investigators in Latin America to establish a successful career path in cancer research.
Letter of intent deadline: September 20, 2022 Featured News and Information Fogarty News Early career researchers in Ethiopia and India find common ground
Global Health Matters, July/August 2022 NIH News Blood-based biomarkers help predict outcomes after traumatic brain Injury
NIH/NINDS news, August 10, 2022 Training Opportunities The Grant Writing Webinar Series for Institutions Building Research and Research Training Capacity is an informational webinar series for faculty and sponsored programs/research development personnel. Attendees will learn considerations for determining research idea and grant writing readiness, selecting opportunities to apply for, effectively writing a grant application, and seeking appropriate feedback. Postdoctoral positions at the National Institute of Allergy and Infectious Diseases (NIAID) are now open in the Virus Ecology Unit within the Laboratory of Virology: Vaccine development against emerging coronaviruses viruses Transmission and development of countermeasures against emerging viruses Field ecology of emerging Viruses Abstract Submission Opportunities The Joint Annual Scientific Health Conference 2022 hosted by Makerere University College of Health Sciences is accepting abstract submissions.
Conference dates: September 21-23, 2022
Submissions due: August 12, 2022 2022 SU-CUGH Global Health Conference, Catalysing Global Health Innovations for Sustainable Development, is accepting submissions for panels, abstracts and satellite sessions.
Conference dates: October 22-30, 2022
Submissions due: August 18, 2022 International Conference on Malignancies in HIV/AIDS (ICMH) hosted by the National Cancer Institute is accepting abstracts.
Conference dates: October 24–25, 2022
Submissions due: August 26, 2022 Consortium of Universities for Global Health (CUGH) 2023 is accepting submissions for panels and abstract.
Conference dates: April 14-16, 2023
Submissions due: September 30, 2022 Conference Abstract Advising Program will connect early-career CUGH and AFREhealth members (advisees) with more experienced CUGH and AFREhealth members (advisors) to improve the quality of abstracts prior to submission. Events Events for global health researchers: August 16
Virtual: NIAID Mosquito Day Webinar August 25
Virtual: NIH Loan Repayment Programs: Supporting the Next Generation of Researchers |
